File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade
Title | GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade |
---|---|
Authors | |
Issue Date | 2017 |
Citation | Cold Spring Harbour Asia Conference on Inflammation: Basic Mechanisms & Relevant Diseases, Suzhou, China, 11-15 December 2017 How to Cite? |
Abstract | Intraperitoneal metastasis is a common occurrence and is usually involved in the poor prognosis of ovarian cancer. Its specific metastatic pattern implies that certain indispensable microenvironmental factors secreted in the peritoneal cavity can direct metastatic ovarian cancer cells to permissive niches for secondary lesion formation. However, the underlying molecular mechanisms are ill defined. Our previous report showed that omentum conditioned medium (OCM), mimicking the omental tumor microenvironment, promotes the oncogenic properties of ovarian cancer cells. Herein, we report that GRO-α and IL-8 are predominately upregulated in OCM derived from either normal or cancerous omenta and are associated with increased ovarian cancer aggressiveness. Both chemokines can activate TAK1/NFκB signaling via the CXCR2 receptor. Intriguingly, TAK1/NFκB signaling activity was higher in metastatic ovarian cancer cells; this higher activity makes them more susceptible to OCM-induced tumor aggressiveness. Treatment of ovarian cancer cells with GRO-α and IL-8 neutralizing antibodies or depletion of CXCR2 by shRNA gene knockdown, CRISPR/Cas9 gene knockout, or CXCR2 inhibitor SB225002 treatment significantly attenuated TAK1/NFκB signaling and decreased in vitro and in vivo oncogenic and metastatic potential, suggesting CXCR2 plays a key role in the GRO-α and IL-8-governed metastatic spreading of ovarian cancer cells in the intraperitoneal cavity. Taken together, our study highlights the significance of GRO-α and IL-8 as the key chemokines in the peritoneal tumor microenvironment and suggests the utility of targeting their receptor CXCR2 as a potential target-based therapy for peritoneal metastases of ovarian cancer. |
Persistent Identifier | http://hdl.handle.net/10722/250611 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, DW | - |
dc.contributor.author | Chen, R | - |
dc.contributor.author | Yung, MH | - |
dc.contributor.author | Ngan, HYS | - |
dc.date.accessioned | 2018-01-18T04:29:44Z | - |
dc.date.available | 2018-01-18T04:29:44Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Cold Spring Harbour Asia Conference on Inflammation: Basic Mechanisms & Relevant Diseases, Suzhou, China, 11-15 December 2017 | - |
dc.identifier.uri | http://hdl.handle.net/10722/250611 | - |
dc.description.abstract | Intraperitoneal metastasis is a common occurrence and is usually involved in the poor prognosis of ovarian cancer. Its specific metastatic pattern implies that certain indispensable microenvironmental factors secreted in the peritoneal cavity can direct metastatic ovarian cancer cells to permissive niches for secondary lesion formation. However, the underlying molecular mechanisms are ill defined. Our previous report showed that omentum conditioned medium (OCM), mimicking the omental tumor microenvironment, promotes the oncogenic properties of ovarian cancer cells. Herein, we report that GRO-α and IL-8 are predominately upregulated in OCM derived from either normal or cancerous omenta and are associated with increased ovarian cancer aggressiveness. Both chemokines can activate TAK1/NFκB signaling via the CXCR2 receptor. Intriguingly, TAK1/NFκB signaling activity was higher in metastatic ovarian cancer cells; this higher activity makes them more susceptible to OCM-induced tumor aggressiveness. Treatment of ovarian cancer cells with GRO-α and IL-8 neutralizing antibodies or depletion of CXCR2 by shRNA gene knockdown, CRISPR/Cas9 gene knockout, or CXCR2 inhibitor SB225002 treatment significantly attenuated TAK1/NFκB signaling and decreased in vitro and in vivo oncogenic and metastatic potential, suggesting CXCR2 plays a key role in the GRO-α and IL-8-governed metastatic spreading of ovarian cancer cells in the intraperitoneal cavity. Taken together, our study highlights the significance of GRO-α and IL-8 as the key chemokines in the peritoneal tumor microenvironment and suggests the utility of targeting their receptor CXCR2 as a potential target-based therapy for peritoneal metastases of ovarian cancer. | - |
dc.language | eng | - |
dc.relation.ispartof | Cold Spring Harbour Asia Conference on Inflammation: Basic Mechanisms & Relevant Diseases | - |
dc.title | GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Chan, DW: dwchan@hku.hk | - |
dc.identifier.email | Yung, MH: mhyung@hku.hk | - |
dc.identifier.email | Ngan, HYS: hysngan@hkucc.hku.hk | - |
dc.identifier.authority | Chan, DW=rp00543 | - |
dc.identifier.authority | Ngan, HYS=rp00346 | - |
dc.identifier.hkuros | 284019 | - |